Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC).

被引：0
|
作者：
Hwang, Clara
Henderson, Nicholas
Cackowski, Frank Cameron
Pilling, Amanda
Jang, Albert
Rothstein, Shoshana
Labriola, Matthew
Park, Joseph J.
Ghose, Alyssa
Bilen, Mehmet Asim
Kilari, Deepak
Tripathi, Abhishek
Garje, Rohan
Koshkin, Vadim S.
Schweizer, Michael Thomas
Armstrong, Andrew J.
Mckay, Rana R.
Dorff, Tanya B.
Alva, Ajjai Shivaram
Barata, Pedro C.
机构：
[1] Henry Ford Hlth Syst, Detroit, MI USA
[2] Univ Michigan, Dept Biostat, Ann Arbor, MI USA
[3] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[4] Tulane Univ, Sch Med, New Orleans, LA USA
[5] Duke Univ, Div Med Oncol, Durham, NC USA
[6] Univ Michigan, Dept Med, Div Hematol & Oncol, Ann Arbor, MI USA
[7] Univ Michigan, Ann Arbor, MI USA
[8] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
[9] Med Coll Wisconsin, Froedtert Canc Ctr, Dept Med, Milwaukee, WI USA
[10] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA
[11] Univ Iowa, Div Hematol Oncol, Dept Internal Med, Iowa City, IA USA
[12] Univ Calif San Francisco, San Francisco, CA USA
[13] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA USA
[14] Duke Univ, Sch Med, Duke Canc Inst, Ctr Prostate & Urol Canc, Durham, NC USA
[15] Univ Calif San Diego Hlth, La Jolla, CA USA
[16] City Hope Comprehens Canc Ctr, Duarte, CA USA
[17] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI USA
[18] Tulane Univ, Sch Med, New Orleans, LA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5013
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Docetaxel rechallenge chemotherapy in metastatic castration-resistant prostate cancer (mCRPC).
    Bracarda, S.
    Sisani, M.
    Rossi, M.
    Galli, L.
    Hamzaj, A.
    Scali, S.
    De Angelis, V.
    Falcone, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [22] FDG and PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Zukotynski, Katherine A.
    Jadvar, Hossein
    Cho, Steve Y.
    Kim, Chun Ki
    Cline, Kathryn
    Emmenegger, Urban
    Hotte, Sebastien J.
    Pond, Gregory Russell
    Winquist, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Cabazitaxel for octogenarian patients with metastatic castration-resistant prostate cancer (MCRPC)
    Tralongo, P.
    Bordonaro, S.
    Di Lorenzo, G.
    Borsellino, N.
    Facchini, G.
    Rossetti, S.
    Martelli, V.
    Longo, V.
    Tralongo, A. C.
    Caspani, F.
    Tuzi, A.
    Spada, M.
    Calvani, N.
    Carlini, P.
    De Giorgi, U. F. F.
    ANNALS OF ONCOLOGY, 2019, 30
  • [24] Use of PSMA PET in metastatic castration-resistant prostate cancer (mCRPC)
    Karunaratna, Nathasha
    Jensen, Andrew
    Wong, Shirley
    Shapiro, Julia
    Weickhardt, Andrew
    Spain, Lavinia
    Azad, Arun
    Kwan, Edmond M.
    Muthusamy, Arun
    Torres, Javier
    Parente, Phillip
    Parnis, Francis
    Goh, Jeffrey
    Gibbs, Peter
    Tran, Ben
    Anton, Angelyn
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 58 - 58
  • [25] Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    Henriquez, Ivan
    Roach, Mack I. I. I. I. I. I.
    Morgan, Todd M.
    Bossi, Alberto
    Gomez, Junior A.
    Abuchaibe, Oscar
    Counago, Felipe
    BIOMEDICINES, 2021, 9 (09)
  • [26] TIMP-1: A potential biomarker of neuroendocrine differentiation in metastatic castration-resistant prostate cancer (mCRPC)
    Gong, Yixuan
    Chippada-Venkata, Uma
    Dai, Xudong
    Galsky, Matthew D.
    Huang, Jiaoti
    CANCER RESEARCH, 2014, 74 (19)
  • [27] Systemic Therapy in Men with Metastatic Castration-resistant Prostate Cancer: A Systematic Review
    Loblaw, D. A.
    Walker-Dilks, C.
    Winquist, E.
    Hotte, S. J.
    CLINICAL ONCOLOGY, 2013, 25 (07) : 406 - 430
  • [28] Correlation between genomic alterations and germline mutations in men with metastatic castration-resistant prostate cancer (mCRPC)
    Llacer Perez, C.
    Oliva Fernandez, L.
    Canada-Higueras, E.
    Saez, M. I.
    Villatoro, R.
    Montesa Pino, A.
    Herrera Imbroda, B.
    Hernandez, D.
    Lozano Mejorada, R.
    Romero Laorden, N.
    Marquez, M.
    Grau, G.
    Pineda, A.
    Lopez, F. J.
    Peinado, P.
    Alameda, D.
    Olmos, D.
    Castro, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S641 - S642
  • [29] Adiposity and response to androgen signaling inhibition (ASI) in men with metastatic castration-resistant prostate cancer (mCRPC)
    Hahn, Andrew Warren
    Tidwell, Rebecca
    Surasi, Devaki Shilpa
    Pilie, Patrick Glen
    Frigo, Daniel
    Subudhi, Sumit Kumar
    Efstathiou, Eleni
    Zurita, Amado J.
    Tu Shi-Ming
    Chapin, Brian Francis
    Fogelman, David R.
    Starbuck, Michael W.
    Corn, Paul G.
    Aparicio, Ana
    McQuade, Jennifer Leigh
    Logothetis, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [30] Combining molecular and functional imaging in metastatic castration-resistant prostate cancer (mCRPC).
    Conteduca, Vincenza
    Scarpi, Emanuela
    Wetterskog, Daniel
    Caroli, Paola
    Romanel, Alessandro
    Lolli, Cristian
    Jayaram, Anuradha
    Gurioli, Giorgia
    Brighi, Nicole
    Poti, Giulia
    Wingate, Anna
    Schepisi, Giuseppe
    Matteucci, Federica
    Paganelli, Giovanni
    Demichelis, Francesca
    Attard, Gerhardt
    De Giorgi, Ugo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
12345